Sunday, February 22, 2015 1:03:27 PM
But please, don't preach how this company should be ran. I have some time today and I'll like to exchange my view about why it's so.
From what I have seen so far, we have a pair of rare commodities in CTIX, one rare commodity is for material B+K (+P?), and the other is for unique combination of business savvy and mutual shareholder loyalty.
Once I saw the Cox interview with Dr. Menon and Mr. Enrlich, I posted here and on YAHOO stock board, saying that CTIX is for really big things. My typical take away from the interview was that the sciences for B+K are so promising, the scientists are so confident sincerely, that MONEY IS NOT EVERYTHING FOR CTIX. A half year later in SF conference, Dr. Menon told Karen EXACTLY THE SAME. BTW, I am reviewing this with you here is because I wanted to tell you that I sometimes know how to read drug developers' minds since I personally know a few drug PI (Primary Investigator).
Yes I believed money is not everything for CTIX in their ultimate goals But CTIX needs money to move forward every steps. Now here comes Mr. Enrlich's business savvy. For past every "probably Leo telegraph too much", a new company development came after. Some time a new talent was hired using stocks. Some time a drug for trial is put in order using stocks. None of those "telegraph too much" is used for a new car, a new house, etc. Most of those "telegraph too much" actually happened in later time. And I am sure you cannot conclude that those yet to happen won't become reality in future.
It is because of MONEY IS NOT EVERYTHING FOR CTIX, we are going to see a life time money making opportunity by investing in CTIX. You can trust me on this. Most of early investors shall be handsomely rewarded. Some like BioHedge, noretreat, BigK might be worth of hundreds of millions in 5 to 10 years.
Of cause I am not very happy with K progresses in DF. Let's be patient.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM